跳转至内容
Merck
CN

ABE1836

Anti-SMARCAL1 Antibody

serum, from rabbit

别名:

SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1, HepA-related protein, hHARP, Sucrose nonfermenting protein 2-like 1, SMARCAL1

登录 查看组织和合同定价。

选择尺寸

关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Anti-SMARCAL1 Antibody, serum, from rabbit

biological source

rabbit

conjugate

unconjugated

antibody form

serum

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human, mouse

technique(s)

immunoprecipitation (IP): suitable
western blot: suitable

NCBI accession no.

NP_001120679

UniProt accession no.

Q9NZC9

shipped in

wet ice

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... SMARCAL1(50485)

Analysis Note

Evaluated by Western Blotting in mouse myoblast C2C12 nuclear extract.

Western Blotting Analysis: A 1:500 dilution of this antibody detected SMARCAL1 in 10 µg of mouse myoblast C2C12 nuclear extract.

Application

Anti-SMARCAL1 Antibody, Cat. No. ABE1836, is a highly specific rabbit Polyclonal antibody, that targets SMARCAL1 and has been tested in Western Blotting, Immunoprecipitation.
Immunoprecipitation Analysis: 3.0 µL from a representative lot immunoprecipitated SMARCAL1 in HEK293T cell lysate (Data courtesy of Dr. David Cortez, Vanderbilt University).
Western Blotting Analysis: A 1:2,000 dilution from a representative lot detected SMARCAL1 in siRNA transfected HEK293T cell lysate (Data courtesy of Dr. David Cortez, Vanderbilt University).
Western Blotting Analysis: A representative lot detected SMARCAL1 in U2OS cell lysate (Bansbach, C.E., et al. (2009). Genes Dev. 23(20):2405-2414).

Biochem/physiol Actions

Reacts with both human and murine SMARCAL1. Expected to react with all four spliced isoforms of murine SMARCAL1.

General description

SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (UniProt Q9NZC9; also known as ATP-driven annealing helicase, HepA-related protein, hHARP, SMARCA-like protein 1, Sucrose nonfermenting protein 2-like 1) is encoded by the SMARCAL1 (also known as HARP, HHARP) gene (Gene ID 50485) in human. The annealing helicase SMARCAL1 is a replication stress response protein that maintains genome integrity at stalled replication forks during DNA replication. SMARCAL1 binds Replication protein A (RPA) via its RPA-binding motif, which is both necessary and sufficient to target SMARCAL1 to stalled replication forks. Although not necessary for SMARCAL1 enzymatic activity, RPA binding is critical for its cellular function. Ataxia-telangiectasia mutated (ATM), ATM and Rad3-related (ATR), and DNA-dependent protein kinase (DNA-PK) phosphorylate SMARCAL1 in response to replication stress. SMARCAL1-deficient cells are hypersensitive to replication stress agents and SMARCAL1 gene mutations cause Schimke immunoosseous dysplasia (SIOD).
~110 kDa observed. Human SMARCAL1 (105.9 kDa calculated). Mouse SMARCAL1 (100.8 kDa/isoform 1, 87.1 kDa/isoform 2, 63.2 kDa/isoform 3, 44.2 kDa/isoform 4 calculated). Uncharacterized band(s) may appear in some lysates.

Immunogen

Recombinant protein corresponding to the N-terminus of human SMARCAL1.

Other Notes

Concentration: Please refer to lot specific datasheet.

未找到合适的产品？  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 1

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Zhe Yang et al.
Genes & development, 34(19-20), 1392-1405 (2020-09-05)
TRF1 facilitates the replication of telomeric DNA in part by recruiting the BLM helicase, which can resolve G-quadruplexes on the lagging-strand template. Lagging-strand telomeres lacking TRF1 or BLM form fragile telomeres-structures that resemble common fragile sites (CFSs)-but how they are

相关内容

White Paper: Further considerations of antibody validation and usage.
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System

A major focus of breast cancer research is to understand the mechanisms responsible for disease progression and drug resistance. Toward that end, it has been found that approximately two thirds of all human breast carcinomas overexpress the Estrogen Receptor α (ERα) protein and it remains the primary pharmacological target for endocrine therapy1,2. The normal cellular function of ERα is as a transcription factor that mediates a wide variety of physiological processes, many of which are dependent upon phosphorylation of the receptor at specific amino acid residues3,4. Indeed, ERα is known to be phosphorylated at a multitude of different sites, yet how these all correlate to disease remains unclear5. Here, we interrogated multiple sites of ERα for phosphorylation status by screening an extensive panel of different breast cancer patient samples and other non-breast cancer tissue microarray (TMA) slide samples to determine their relevance to disease.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持